‹ All Posts
Saurabh Tyagi--Clovek,Advisory

21st Feb 2025 · SEBI-Registered Analyst

MAHLIFE
approves investment.

MAHLIFE
a approves investment in rights issues of subsidiaries MMFSL (up to Rs. 3,000 Cr) and MLDL (up to Rs. 1,500 Cr). FY2024 consolidated revenues: MMFSL Rs. 15,797 Cr, MLDL Rs. 212.09 Cr.

#StockInNews#FundamentalViews#MacroViews#EquityResearch
185 likes·30 comments